We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA GUIDANCE DEFINES THE TERM 'AVAILABLE THERAPY'
FDA GUIDANCE DEFINES THE TERM 'AVAILABLE THERAPY'
July 22, 2004
In regulations and policy statements where the term "available therapy" is not defined, the phrase should be interpreted as therapy that is specified in the approved labeling of regulated products, with only rare exceptions, the FDA said yesterday in a guidance that aims to clarify the term.